|
|
Conference:
Pre-conference workshop
28 April 9am - 5pm
Day 1
29 April 8.30am - 5:30pm
Day 2
30 April 8.30am - 5:30pm
Post-conference workshop
1 May 9am - 5pm
Main venue: Radisson SAS Portman Hotel, London, United Kingdom
› Email a colleague
› Add this to my calendar
|
Dr Carole Longson
Health Technology Evaluation Director
NICE, UK
Dr Martin van der Graaf
Secretary Reimbursement Committee
CVZ, Netherlands
Dr Brien Benoit
Chairman
Patented Medicine Prices Review Board
Professor Silvio Garattini
Founder
Mario Negri Institute, Italy
Plus representation from:
HAS, BlueCross BlueShield, GBA, Johnson & Johnson, Serono, Baxter.
|
|
|
|
Meet the sponsors and exhibitors
|
UBC
|
|
United BioSource Corporation (UBC) is a global pharmaceutical and medical device services organization that combines deep scientific knowledge with broad execution expertise across the product lifecycle. Our focus is strategizing to identify, analyze and present real-world evidence to support the development and commercialization of medical products for emerging and established life science companies.
We partner with our clients to meet their needs with:
- Experts to provide strategic planning to guide evidence generation strategies and plans;
- Scientific leadership in epidemiology, health economics, outcomes research, meta-analysis, data capture and biostatistics;
- Extensive experience in pre - and post-approval research;
- Clinical and strategic development services for emerging life science companies;
- Data integrity and technology services to support training clinical professionals and managing clinical data from study conception to completion;
- Investigator and patient programs to support investigators, study site personnel, clinical research subjects and patients;
- Medical education, communication and market access programs.
With over 1200 staff members, we are strategically positioned throughout North America and Europe and specialize in offering innovative ways to study drugs and devices with an emphasis on science, strategy, and execution.
|
|
The Evidence Research Unit
|
|
The Evidence Research Unit is a specialised team within Complete Medical Group (CMG). We are experts in communicating product value and supporting successful market access initiatives, built on a platform of quality, flexibility and robust scientific methodology, in partnership with our customers.
Established in 1999 in response to the changing needs of healthcare providers and professionals, we have worked with more 30 pharmaceutical companies at global and pan-European levels, and within many specific countries. We have experience across a broad spectrum of therapy areas using a range of technical expertise focused towards payers and healthcare decision-makers.
We deliver high-quality research, analysis and communications that can help you:
- Generate and communicate health economic and outcomes data and messages
- Identify the impact of healthcare policy in a range of markets
- Communicate global market access strategy for implementation at a local level
- Demonstrate the value of your product to payers and prescribers
- Leverage the evidence base for your product through systematic reviews, critical data appraisal and meta-analyses
- Conduct strategic environmental reviews and situational analyses to inform value strategy
- Seek payer insights to inform and strengthen your value demonstration plans and reimbursement strategy
|
|
RTI Health Solutions
|
|
To generate insights for our clients into the pricing and reimbursement (P&R) environment for pharmaceuticals, biotechnologies, medical devices, and diagnostics, RTI Health Solutions (RTI‑HS) offers a range of services, spanning many markets, including:
- Global P&R strategies;
- International pharmaceutical prices: database and analysis;
- Customized payer research;
- Value dossier and reimbursement submissions; and
- Health economics
An effective P&R strategy is a key component of the international marketing plan. Our global P&R strategies are underpinned by an extensive database of international pharmaceutical prices, access to local market expertise in many markets throughout the world, and by our payer research capabilities.
For more information contact: Neil Palmer, Vice President, Pricing & Reimbursement
|
|
Abt Bio-Pharma Solutions
|
|
At Abt Bio-Pharma Solutions, Inc. (ABS), we create custom solutions to help clients in the pharmaceutical, biotechnology, medical device, and diagnostics industries achieve competitive advantage worldwide. We offer an array of integrated strategic, research, and communications services to guide decisions throughout the product lifecycle.
Sponsors use our global, clinically-driven reimbursement solutions, integrated with health economics and outcomes research, to demonstrate and communicate product value and promote reimbursement and pricing success. Our expertise extends to medical devices as well as oral and injectable pharmaceuticals, biotechnology agents and processes, vaccines, and diagnostic tests, as they are used in multiple settings of care (physician office, hospital in-patient and out-patient, nursing homes).
As a full-service team, ABS conducts qualitative and quantitative research with payers, physicians, patients and other stakeholders, as well as secondary research related to legislation, public payer coverage policies, disease incidence and prevalence, and competitor strategies. Our senior, seasoned staff help sponsors develop their research agendas, successfully conduct their research programs, and communicate the results to internal and external audiences. Additional service offerings include registries and other late-phase clinical studies, strategic commercialization services, and biometrics.
|
|
Oxford Outcomes
|
|
Oxford Outcomes Ltd provides multi-disciplinary approaches and effective solutions in health economics, patient reported outcomes, PRO translations, and epidemiology.
● Health Economics ● Patient Reported Outcomes ● Epidemiology ● Translations and Cultural Adaptation ● Pricing Research ● Training, Workshops, Conferences ● Dissemination
We have established offices in Oxford (UK), Vancouver (Canada), and Bethesda (US).
The company is founded on a belief in practical and effective solution that are designed to meet the exact needs of the client. We believe in:
- Drawing together the benefits of academic research and focused project management
- Seeking practical, effective solutions wherever possible, but turning to innovation where existing methods can be improved
- Continuing to provide specialised service in outcomes research, health economics and epidemiology.
- Innovating and developing the interface between our three core disciplines.
Our human capital is of paramount importance to us, and we recognise that the quality of our services depends on the expertise within our team. We have therefore built a high-calibre team with an interest in our research and consultancy.
We have a well-developed international network of consultants and experts. This network is built around our strong academic and professional links and gives us the capability to undertake projects across Europe, North America, South America, Asia, Australasia and parts of Africa.
We are also a member of COPERA. Established in 2006, COPERA is a multi-national consortium of consulting groups with capability to undertake multi-country projects across Europe and North America.
|
|
Heron
|
|
HERON was founded in the UK in 1999 by Paul Howard, John Kerrigan and Chris Knight. The company is still wholly owned by the three co-founders.
HERON's core business is the field of health outcomes and pricing and reimbursement. Our competencies in this sector are built on a strong foundation in data analytics which underpin our leading commercial position in systematic review and meta-analysis. This ‘data and evidence core’ shapes and feeds HERON’s other main service areas in pricing and reimbursement and economic evaluation. These skills together with experience and proven success in global programmes, are driving rapid growth in capacity and geographic expansion.
The development of a stand-alone analytics hub in Chandigarh, India is designed to uniquely position HERON in the health outcomes sector. HERON's US organisation provides localised customer service in this key market.
|
|
Pharmerit
|
|
Pharmerit is a research organization based in Rotterdam in the Netherlands, Bethesda, MD, USA, and York in the United Kingdom. With its global reach, Pharmerit's mission is to improve patients' access to medical care through evidence--worldwide.
Pharmerit puts its team of leading scientists, clinicians, methodologists, strategists, pricing and reimbursement specialists and academicians to the task of understanding, shaping and communicating the value of health care interventions.
We conduct Health Economic and Outcomes Research to inform local, national, and international decision makers in pharmaceutical, biotechnology, device, and diagnostic companies, government bodies and private organizations involved in the delivery and financing of health care.
Whether you need to evaluate the value of a new treatment in early stage of development, assess the unmet needs for a product's new indication, determine the quality of life impact of a new therapy, design or interpret the results of a clinical trial, or define a reimbursement strategy, chances are that our team, with over 125 years of combined experience, has successfully addressed this or a very similar problem numerous times in the past.
Whatever the unique and specific challenges you face, you will find in working with Pharmerit a team of researchers dedicated to find customized, authoritative and timely answers that have practical and actionable implications for you and other decision makers.
|
|
Bridgehead International
|
|
Bridgehead is a leading, international, consultancy group specialising in the Healthcare sector. We assist clients in achieving market access and growth across the product and technology value chain. We have over 50 consultants and associates in Europe, North America and Asia, providing a powerful combination of strategic, scientific, medical, technical, commercial, economic, decision support, modelling and intellectual property skills and experience. We work for leading pharmaceutical, biotechnology and medical device companies, and financial institutions. Our key services include:
Market access solutions
- Product development/commercialisation support
- Payer research and market access studies
- Pricing strategy and reimbursement negotiation
- Market access support
- Pharmacoeconomic assessments & modelling
- Health outcomes research
- Unmet needs assessment
- Therapy area environmental scanning
- Key opinion leader investigations
- Advisory boards
- Portfolio review
- Workshops & training/education
Transaction support
- Due diligence, including technical, clinical and commercial
- Product search
- Deal benchmarking
- Sales forecasting and valuation
|
To find out more about becoming a sponsor contact James Hopkins on +44 (0) 207 608 7038
|
|
|
|
|
Reserve an exhibition stand at Pharma Pricing & Market Access Outlook 2009 - book early to ensure optimum stand placement!
| |
Reserve a stand
For details contact
James Hopkins on +44 (0) 207 608 7038
|
|
|
|
|
|
